Figure 5.
SLAP interferes with Epo-induced differentiation of EI/11 erythroblasts. (A) Expression of exogenous SLAP protein in EI/11-eGFP/SLAP culture was analyzed by Western blotting using an anti-Flag antibody. (B) Hemoglobin content in control eGFP and eGFP/SLAP cells maintained under proliferation conditions (day 0) and after differentiation induction for 1, 2, 3, and 4 days in the presence of Epo. Values were normalized with respect to cell number and volume (hemoglobin level per 106 live cells). The mean value and standard deviation of triplicate measurements are shown. (C) Quantitative evaluation of apoptosis by TUNEL assay in eGFP and eGFP/SLAP cells maintained in differentiation conditions for 48 or 72 hours. (D) RT-PCR analysis of BCL-XL mRNA expression in control eGFP and eGFP/SLAP erythroblasts maintained under either proliferative conditions (0 hours) or induced to differentiate for 48 hours in the presence of Epo. The mean value and standard deviation of 3 independent fields are shown. (D) PCR was carried out using 0.5 μL and 1 μL RT reactions. Primers used were specific for either the BCL-XL gene (top blot) or the β-Actin gene as normalization control (bottom blot). The expected 610-bp BCL-xL fragment and 540-bp Actin gene fragment are indicated.